During the past decade, Genesis Healthcare Partners conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Genesis Healthcare Partners" are "Prostate Cancer" (2 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "Genesis Healthcare Partners" in a lesser frequency.

Most popular intervention types in "Genesis Healthcare Partners" are "Drug" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone/prednisone" (1 trials), "Enzalutamide" (1 trials), "GTx-758 125 mg" (1 trials), "GTx-758 250 mg" (1 trials) and "Invitae multi-cancer gene panel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Healthcare Partners" are 3 trials for "Male" genders.

Currently, there are NaN active trials in "Genesis Healthcare Partners". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Genesis Healthcare Partners, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Healthcare Partners, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Genesis Healthcare Partners has several departments that took part in Clinical trials: "Center for Urological Research" - 6 trials, "Hillcrest Urological Medical Group, Inc." - 2 trials